Envoy Medical, Inc. Overview
Pro stress-test →Envoy Medical (NASDAQ: COCH) is a hearing health company focused on providing innovative technologies across the hearing loss spectrum. The company has pioneered fully implanted devices including the Esteem® active middle ear implant, commercially available in the U.S. since 2010, and the fully implanted Acclaim® cochlear implant, an investigational device.
Strategic Profile
Pro stress-test →The Acclaim Cochlear Implant is designed to be the first fully implanted cochlear implant, featuring a sensor designed to leverage the natural anatomy of the ear instead of a microphone to capture sound. The device received FDA Breakthrough Device Designation in 2019. As of April 2026, the company completed enrollment of its pivotal clinical trial with all 56 patients having completed their activation visits.
Competitive Landscape
Pro stress-test →Competitors are now openly discussing fully implanted plans, though Envoy believes its sensor technology and overall architecture provides a better solution than competitors pursuing total implantation. Primary competitors include traditional cochlear implant manufacturers (Cochlear, Advanced Bionics/Sonova, MED-EL) transitioning toward miniaturized and implanted solutions.
Industry Context
Envoy Medical, Inc. operates in Medical Devices - Hearing Implants & Audiology Solutions.
Key facts
Founded: 1995 · Headquarters: White Bear Lake, Minnesota, US